BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 3898297)

  • 1. Thymopentin in active rheumatoid arthritis. An open, monitored study in 16 patients.
    Franchimont P; Hauwaert C; Bolla K
    Surv Immunol Res; 1985; 4 Suppl 1():81-6. PubMed ID: 3898297
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Immunomodulating therapy in chronic polyarthritis with thymopentin. A multicenter placebo-controlled study of 119 patients].
    Lemmel EM; Bach GL; Bolten W; Brackertz D; Fahmy Z; Mattern H; Stroehmann I; Wittenborg A
    Dtsch Med Wochenschr; 1988 Feb; 113(5):172-6. PubMed ID: 3276492
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interim results on the clinical effects of i.v. administered thymopentin in active rheumatoid arthritis.
    Malaise M; Franchimont P; Hauwaert C; Danneskiold-Samsoe B; Gross D; Gerber H; Gerschpacher H; Bolla K
    Int J Clin Pharmacol Res; 1984; 4(6):451-7. PubMed ID: 6398314
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Confirmative study of the effectiveness of thymopentin in active rheumatoid arthritis.
    Malaise M; Franchimont P; Hauwaert C; Danneskiold-Samsoe B; Gross D; Gerber H; Gerschpacher H; Bolla K
    Surv Immunol Res; 1985; 4 Suppl 1():87-93. PubMed ID: 3898298
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thymopentin treatment of herpes simplex infections. An open, monitored, multicenter study.
    DeMaubeuge J; Haneke E; Djawari D; Wolff K; Stingl G; Molin L; Schöpf E; Stengel R; Degreef H; Panconesi E
    Surv Immunol Res; 1985; 4 Suppl 1():30-6. PubMed ID: 2863860
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thymopentin in chronic Trichophyton rubrum infection.
    Molin L; Bolla K
    Surv Immunol Res; 1985; 4 Suppl 1():135-8. PubMed ID: 3898286
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety of thymopentin. Data from European clinical studies.
    Weiss P; Stocker H
    Surv Immunol Res; 1985; 4 Suppl 1():149-54. PubMed ID: 3898288
    [TBL] [Abstract][Full Text] [Related]  

  • 8. First observations on high-dosed and long-term thymopentin treatment in active rheumatoid arthritis.
    Molin L; Schmid F; Bolla K
    Int J Clin Pharmacol Res; 1984; 4(6):445-9. PubMed ID: 6398313
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Thymopentin in the treatment of recurrent condylomata acuminata].
    Ghetti P; Negosanti M; Andriani GC; Beltrandi E; Maldini M
    Minerva Ginecol; 1989 Feb; 41(2):113-6. PubMed ID: 2664577
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rationale for thymopentin as therapeutic agent in rheumatoid arthritis.
    Franchimont P; Bolla K
    Surv Immunol Res; 1985; 4 Suppl 1():70-5. PubMed ID: 3898295
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A case of juvenile rheumatoid arthritis treated with thymopentin].
    Tucciarone L; Felici W; Greco L; Mechelli A
    Minerva Pediatr; 1989 Feb; 41(2):109-11. PubMed ID: 2661988
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thymopentin (TP-5) in the treatment of rheumatoid arthritis.
    Kantharia BK; Goulding NJ; Hall ND; Davies J; Maddison PJ; Bacon PA; Farr M; Wojtulewski JA; Englehart KM; Liyanage SP
    Br J Rheumatol; 1989 Apr; 28(2):118-23. PubMed ID: 2650797
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thymopoietin pentapeptide (thymopentin, TP-5) in the treatment of rheumatoid arthritis. A compilation of several short- and longterm clinical studies.
    Veys EM; Mielants H; Verbruggen G; Spiro T; Newdeck E; Power D; Goldstein G
    J Rheumatol; 1984 Aug; 11(4):462-6. PubMed ID: 6384507
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of thymopentin treatment on the relapse rate in frequently relapsing herpes simplex virus infections.
    Haneke E; Bolla K; Degreef H; Djawari D; Demaubeuge J; Molin L; Panconesi E; Schöpf E; Stengel R; Stingl G
    Int J Clin Pharmacol Res; 1984; 4(6):439-43. PubMed ID: 6085327
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Thymopentin and immune response in patients with cancer].
    Petronella P; Ferrone R; Freda F; Valeriani G
    Minerva Chir; 1989 Sep; 44(18):2017-20. PubMed ID: 2694011
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thymopentin in the treatment of alopecia areata.
    Orecchia G
    Dermatologica; 1989; 178(4):231. PubMed ID: 2670621
    [No Abstract]   [Full Text] [Related]  

  • 17. Influence of thymopentin on postsurgical immune deficiency: a clinical pilot study.
    Faist E; Riedel A; Bolla K
    Int J Clin Pharmacol Res; 1987; 7(1):83-7. PubMed ID: 3294617
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Thymopentin in the treatment of cutaneous melanoma].
    Trevisan G; Agolzer A
    G Ital Dermatol Venereol; 1989 May; 124(5):245-9. PubMed ID: 2695455
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Efficacy and tolerability of thymopoietin in patients at risk of infection].
    Recenti Prog Med; 1987; 78(7-8):358-64. PubMed ID: 3321257
    [No Abstract]   [Full Text] [Related]  

  • 20. Experience with thymopentin in the treatment of periarthritis humeroscapularis, tendinitis, and gonarthrosis by local infiltration.
    Pipino F; Vittore D
    Arzneimittelforschung; 1988 Jan; 38(1):116-9. PubMed ID: 3284530
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.